Create a management protocol for sepsis in the ICU

Reading Document
Medical Text Search

sepsis ICU management protocol diagnosis criteria Surviving Sepsis Campaign

Medical Text Search

sepsis resuscitation fluid therapy vasopressors hemodynamic targets

GradeResponse
GradeResponse
Medical Text Search

sepsis antibiotic therapy source control empiric broad spectrum

Medical Text Search

septic shock organ support mechanical ventilation renal replacement corticosteroids

Here is a comprehensive ICU sepsis management protocol based on the Surviving Sepsis Campaign (SSC) guidelines and Harrison's Principles of Internal Medicine.

ICU Sepsis Management Protocol

1. Definitions (Sepsis-3, 2016)

TermDefinition
SepsisLife-threatening organ dysfunction caused by a dysregulated host response to infection (SOFA score increase ≥2 points)
Septic ShockSepsis + vasopressor requirement to maintain MAP ≥65 mmHg + serum lactate >2 mmol/L despite adequate fluid resuscitation
qSOFA (bedside screen)RR ≥22/min, altered mentation, SBP ≤100 mmHg — ≥2 points warrants further evaluation

2. Initial Recognition & Workup (Hour 0–1)

Investigations — obtain before antibiotics if it does not cause delay:
  • Blood cultures ×2 (peripheral + central line if present)
  • Urine, sputum, wound cultures as clinically indicated
  • CBC with differential, CMP, coagulation panel (PT/aPTT/fibrinogen)
  • Serum lactate (arterial or venous)
  • Procalcitonin (baseline for antibiotic stewardship)
  • ABG, chest X-ray, ECG
  • Focused bedside echocardiography (cardiac function, volume status)
  • SOFA score calculation (assess organ dysfunction)

3. Resuscitation Bundle — "Hour-1 Bundle" (SSC 2018)

Sepsis and septic shock are emergencies. All steps should be initiated simultaneously.
  1. Measure lactate — re-measure if initial >2 mmol/L
  2. Blood cultures — obtain before antibiotics
  3. Administer broad-spectrum antibiotics — within 1 hour of recognition
  4. IV crystalloid 30 mL/kg — for hypotension or lactate ≥4 mmol/L, delivered within 3 hours
  5. Vasopressors — if patient remains hypotensive during/after fluids to maintain MAP ≥65 mmHg

4. Fluid Resuscitation

ConsiderationRecommendation
Fluid typeBalanced crystalloids (Lactated Ringer's) preferred; normal saline is acceptable
Initial bolus30 mL/kg IV crystalloid within 3 hours
AvoidHydroxyethyl starches (HES), gelatins
ReassessmentDynamic measures of fluid responsiveness (pulse pressure variation, stroke volume variation, passive leg raise test) after initial bolus
Lactate-guidedTarget lactate normalization (<2 mmol/L) as a resuscitation endpoint
Avoid fluid overload — reassess after each bolus using clinical and hemodynamic parameters. A conservative fluid strategy post-resuscitation is associated with improved outcomes.

5. Vasopressors & Hemodynamic Support

AgentRoleNotes
NorepinephrineFirst-line vasopressorTarget MAP ≥65 mmHg; higher targets (80–85) may benefit select patients (chronic HTN)
VasopressinAdd-on to reduce NE dose0.03–0.04 units/min; do not use as sole agent
EpinephrineSecond-line add-onWhen NE + vasopressin insufficient
DopamineAvoid in most casesOnly in select bradycardic patients at low risk of tachyarrhythmia
DobutamineCardiac output supportAdd to vasopressor if myocardial dysfunction with evidence of tissue hypoperfusion
PhenylephrineAvoid in septic shockMay worsen cardiac output
Monitoring: Arterial line (continuous MAP), central venous access, serial lactate measurements every 2 hours until normalized.

6. Antimicrobial Therapy

Timing

  • Administer within 1 hour of sepsis/septic shock recognition
  • Each hour of delay increases mortality

Empiric Regimen Selection

Clinical ScenarioSuggested Regimen
Community-acquired (unknown source)Piperacillin-tazobactam + vancomycin
Hospital/ICU-acquiredMeropenem or imipenem ± vancomycin ± antifungal
Neutropenic/immunocompromisedAnti-pseudomonal beta-lactam + vancomycin ± antifungal
Suspected MRSAAdd vancomycin or linezolid
Suspected fungal (Candida)Add echinocandin (micafungin, caspofungin)
Abdominal sourcePiperacillin-tazobactam or meropenem (anaerobic coverage)
MeningitisCeftriaxone + vancomycin + dexamethasone ± ampicillin (Listeria risk)

Antibiotic Stewardship

  • De-escalate based on culture results and clinical improvement (typically 48–72 hours)
  • Duration: 7–10 days in most patients; procalcitonin-guided cessation reduces duration
  • Reassess daily for appropriateness

7. Source Control

  • Identify and control infectious source within 6–12 hours of diagnosis
  • Interventions: drainage of abscess, removal of infected devices/catheters, debridement of infected tissue, surgical intervention
  • Least invasive effective intervention preferred (e.g., percutaneous drainage over open surgery)
  • Remove intravascular access devices suspected as source after new access established

8. Organ Support

A. Respiratory

ParameterTarget/Recommendation
Mechanical ventilationFor sepsis-induced ARDS (PaO₂/FiO₂ <300)
Tidal volume6 mL/kg predicted body weight (lung-protective)
Plateau pressure≤30 cmH₂O
PEEPTitrate to optimize oxygenation; high PEEP strategy for moderate-severe ARDS
Prone positioningFor PaO₂/FiO₂ <150 despite optimization — ≥16 hours/day
SpO₂ target92–96%
Conservative O₂Avoid hyperoxia (SpO₂ >96% without indication)

B. Renal

  • Continuous renal replacement therapy (CRRT) preferred over intermittent HD in hemodynamically unstable patients
  • Initiate RRT for: refractory hyperkalemia, severe acidosis, fluid overload unresponsive to diuretics, uremia
  • Avoid nephrotoxic agents (NSAIDs, aminoglycosides, contrast where possible)

C. Hepatic / GI

  • Early enteral nutrition within 24–48 hours if feasible
  • Trophic feeding acceptable in early ARDS
  • Stress ulcer prophylaxis (PPI or H2 blocker) in high-risk patients
  • DVT prophylaxis (LMWH preferred over UFH unless contraindicated)

D. Hematologic

  • Transfuse RBCs for Hgb <7 g/dL (target 7–9 g/dL) — higher threshold (8–9) in cardiac ischemia
  • Platelets: transfuse if <10,000/μL (prophylactic) or <50,000/μL with active bleeding/planned procedure
  • FFP only for active bleeding or invasive procedures with coagulopathy — not prophylactically

9. Endocrine & Metabolic Management

ParameterTarget/Recommendation
Blood glucose140–180 mg/dL; use insulin infusion protocol
Avoid hypoglycemiaMonitor glucose every 1–2 hours when on insulin infusion
CorticosteroidsHydrocortisone 200 mg/day IV (continuous or 50 mg q6h) if septic shock not responsive to adequate fluids + vasopressors
Sodium bicarbonateConsider if pH <7.15 with AKI (not for lactic acidosis alone)

10. Monitoring & Reassessment Targets

ParameterTarget
MAP≥65 mmHg
Serum lactate<2 mmol/L (normalize within 6 hours)
Urine output≥0.5 mL/kg/hr
CVP8–12 mmHg (12–15 if mechanically ventilated)
Central venous O₂ sat (ScvO₂)≥70%
Capillary refill time<3 seconds
SpO₂92–96%

11. What to Avoid

  • ❌ Hydroxyethyl starches or gelatins for resuscitation
  • ❌ Dopamine as first-line vasopressor
  • ❌ Tight glycemic control (target <110 mg/dL) — increases hypoglycemia risk
  • ❌ Routine use of stress-dose steroids without refractory shock
  • ❌ Routine use of IV immunoglobulin, selenium, or antioxidants
  • ❌ Prolonged antibiotic courses without reassessment
  • ❌ High tidal volumes in mechanically ventilated patients

12. Sepsis Checklist Summary

Hour 0–1:
  □ Measure serum lactate
  □ Blood cultures ×2 before antibiotics
  □ Administer broad-spectrum antibiotics
  □ Begin IV crystalloid 30 mL/kg
  □ Start norepinephrine if MAP <65 despite fluids

Hours 1–6:
  □ Re-measure lactate if initial >2 mmol/L
  □ Reassess volume status (echo, dynamic measures)
  □ Identify and control infectious source
  □ Initiate organ support (ventilation, RRT as needed)
  □ Begin insulin protocol if glucose >180 mg/dL
  □ DVT + stress ulcer prophylaxis

Ongoing:
  □ Daily reassessment and antibiotic de-escalation
  □ Corticosteroids if refractory vasopressor-dependent shock
  □ Nutritional support
  □ Rehabilitative care planning

References:
  • Surviving Sepsis Campaign (SSC) 2018/2021 Guidelines — Evans et al., Intensive Care Med 2021
  • Harrison's Principles of Internal Medicine, 21st Edition, p. 8273
  • Bailey and Love's Short Practice of Surgery, 28th Edition, p. 80
  • Sepsis-3 Consensus Definitions — Singer et al., JAMA 2016
This is a shared conversation. Sign in to Orris to start your own chat.